Planned enrollment increased by 160 participants
Before: 165 participants (planned). After: 325 participants (planned).
Study sponsor: Kiniksa Pharmaceuticals International, plc · KNSA
Primary completion is the date data collection ends for the main study measures, not when results are published.
Before: 165 participants (planned). After: 325 participants (planned).